Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-05T13:13:53.369Z Has data issue: false hasContentIssue false

Manuka honey mouthwash does not affect oral mucositis in head and neck cancer patients in New Zealand

Published online by Cambridge University Press:  23 November 2011

Emma Parsons
Affiliation:
Regional Cancer Treatment Service, Palmerston North Hospital, Palmerston North, New Zealand
Aubrey Begley
Affiliation:
Wellington Blood and Cancer Centre, Wellington Hospital, Wellington, New Zealand
Patries Herst*
Affiliation:
Department of Radiation Therapy, University of Otago, Wellington, New Zealand
*
Correspondence to: PM Herst, Department of Radiation Therapy, University of Otago, Wellington, PO Box 7343, Wellington, New Zealand. Tel: 64 4 3855475. Fax: 64 4 3855375. E-mail: [email protected]

Abstract

Oral mucositis is an unavoidable side effect of radiation therapy to the head and neck, which can compromise patient health and quality of life. This study investigates the effect of manuka honey on the extent of oral mucositis in head and neck patients in New Zealand. A total of 28 patients were recruited; 10 patients received standard care and 18 patients were given additional manuka honey. Honey was used three times a day; assessment included: extent of oral mucositis using a multi-site mucositis scoring system, weight and quality of life. The first six patients, randomised to the honey arm, used undiluted honey and pulled out in the first week because of extreme nausea, vomiting and stinging sensations in the mouth. The next 12 honey patients used a honey mouthwash (diluted 1:3). Six of these patients completed the trial and four more completed the first 4 weeks of the trial. Eight control patients completed the trial. In contrast to previous honey trials in Malaysia, Egypt, Iran and India, diluted manuka honey did not decrease the extent and onset of radiation-induced oral mucositis but did appear to ameliorate radiation-induced weight loss and increase quality of life in the absence of cisplatin chemotherapy.

Type
Original Article
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ministry of Health. Cancer: New Registrations and Deaths 2007. Wellington: Ministry of Health. 2010.Google Scholar
Clarkson, JE, Worthington, HV, Furness, S, McCabe, M, Khalid, T, Meyer, S. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2010; CD001973.CrossRefGoogle ScholarPubMed
Rogers, SN, Ahad, SA, Murphy, AP. A structured review and theme analysis of papers published on ‘quality of life’ in head and neck cancer: 2000–2005. Oral Oncol 2007; 43:843868.CrossRefGoogle ScholarPubMed
Elting, LS, Cooksley, CD, Chambers, MS, Garden, AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007; 68:11101120.CrossRefGoogle ScholarPubMed
Rosenthal, DI, Trotti, A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 2009; 19:2934.CrossRefGoogle ScholarPubMed
Keefe, DM, Schubert, MM, Elting, LS, Sonis, ST, Epstein, JB, Raber-Durlacher, JE, Migliorati, CA, McGuire, DB, Hutchins, RD, Peterson, DE; Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109:820831.CrossRefGoogle ScholarPubMed
Mavric, E, Wittmann, S, Barth, G, Henle, T. Identification and quantification of methylglyoxal as the dominant antibacterial constituent of Manuka (Leptospermum scoparium) honeys from New Zealand. Mol Nutr Food Res 2008; 52:483489.CrossRefGoogle ScholarPubMed
Molan, PC. The evidence supporting the use of honey as a wound dressing. Int J Low Extrem Wounds 2006; 5:4054.CrossRefGoogle ScholarPubMed
Chambers, J. Topical manuka honey for MRSA-contaminated skin ulcers. Palliat Med 2006; 20:557.CrossRefGoogle ScholarPubMed
van den Berg, AJ, van den Worm, E, van Ufford, HC, Halkes, SB, Hoekstra, MJ, Beukelman, CJ. An in vitro examination of the antioxidant and anti-inflammatory properties of buckwheat honey. J Wound Care 2008; 17:172–4, 176.CrossRefGoogle Scholar
Mesaik, MA, Azim, MK, Mohiuddin, S. Honey modulates oxidative burst of professional phagocytes. Phytother Res 2008; 22:14041408.CrossRefGoogle ScholarPubMed
Leong, AG, Herst, PM, Harper, JL. Indigenous New Zealand honeys exhibit multiple anti-inflammatory activities. Innate Immun 2011 Oct 6, [Epub ahead of print].Google ScholarPubMed
Biswal, BM, Zakaria, A, Ahmad, NM. Topical application of honey in the management of radiation mucositis: a preliminary study. Support Care Cancer 2003; 11:242248.CrossRefGoogle ScholarPubMed
Motallebnejad, M, Akram, S, Moghadamnia, A, Moulana, Z. et al. The effect of topical application of pure honey on radiation-induced mucositis: a randomized clinical trial. J Contemp Dent Pract 2008; 9:4047.CrossRefGoogle ScholarPubMed
Rashad, UM, Al-Gezawy, SM, El-Gezawy, E, Azzaz, AN. Honey as topical prophylaxis against radiochemotherapy-induced mucositis in head and neck cancer. J Laryngol Otol 2009; 123:223228.CrossRefGoogle ScholarPubMed
Khanal, B, Baliga, M, Uppal, N. Effect of topical honey on limitation of radiation-induced oral mucositis: an intervention study. Int J Oral Maxillofac Surg 2010; 39:11811185.CrossRefGoogle ScholarPubMed
Epstein, JB, Silverman, S Jr, Paggiarino, DA, Crockett, S, Schubert, MM, Senzer, NN, Lockhart, PB, Gallagher, MJ, Peterson, DE, Leveque, FG. Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: results from a multicenter, randomized, double-blind, placebo-controlled clinical trial. Cancer 2001; 92:875885.3.0.CO;2-1>CrossRefGoogle ScholarPubMed
Aaronson, NK, Ahmedzai, S, Bergman, B, Bullinger, M. et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1933; 85:365376.CrossRefGoogle Scholar
Bjordal, K, Hammerlid, E, Ahlner-Elmqvist, M, de Graeff, A, Boysen, M, Evensen, JF, Biörklund, A, de Leeuw, JR, Fayers, PM, Jannert, M, Westin, T, Kaasa, S. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999; 17:10081019.CrossRefGoogle ScholarPubMed